Dis-Chem Pharmacies Limited (JSE:DCP)

Market Cap	25.32B -11.8%
Revenue (ttm)	42.83B +9.3%
Net Income	978.89M -17.0%
EPS	1.14 -17.0%
Shares Out	856.11M
PE Ratio	25.92
Forward PE	20.50
Dividend	0.45 (1.54%)
Ex-Dividend Date	Jun 17, 2026

Volume	11,667
Open	2,958.00
Previous Close	2,958.00
Day's Range	2,934.00 - 2,960.00
52-Week Range	2,921.00 - 3,900.00
Beta	0.30
Analysts	Buy
Price Target	3,718.75 (+26.45%)
Earnings Date	Oct 30, 2026

About Dis-Chem Pharmacies

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1978
• Employees: 20,000
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: DCP

Financial Performance

In fiscal year 2026, Dis-Chem Pharmacies's revenue was 42.83 billion, an increase of 9.33% compared to the previous year's 39.17 billion. Earnings were 978.89 million, a decrease of -17.03%.

Analyst Summary

According to 8 analysts, the average rating for DCP stock is "Buy." The 12-month stock price target is ZAC 3,719, which is an increase of 26.45% from the latest price.

Price Target

ZAC 3,719

(26.45% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error